TISEO, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 508
EU - Europa 302
AS - Asia 75
AF - Africa 10
SA - Sud America 5
Totale 900
Nazione #
US - Stati Uniti d'America 506
IT - Italia 129
DE - Germania 50
SG - Singapore 32
IN - India 29
AT - Austria 22
NL - Olanda 20
FI - Finlandia 17
IE - Irlanda 14
SE - Svezia 12
CN - Cina 10
RU - Federazione Russa 10
GB - Regno Unito 9
TG - Togo 9
FR - Francia 6
AR - Argentina 4
UA - Ucraina 4
BG - Bulgaria 3
CA - Canada 2
ES - Italia 2
IR - Iran 2
PL - Polonia 2
BD - Bangladesh 1
BJ - Benin 1
BR - Brasile 1
GR - Grecia 1
PS - Palestinian Territory 1
RO - Romania 1
Totale 900
Città #
Fairfield 81
Rome 48
Seattle 48
Ashburn 37
Chandler 37
Woodbridge 37
Houston 29
Singapore 28
Dearborn 24
Cambridge 23
Wilmington 22
Vienna 17
Princeton 15
Dublin 14
Helsinki 14
Naaldwijk 13
San Paolo di Civitate 12
New York 10
Ann Arbor 9
Lawrence 9
Lomé 9
Millbury 8
San Diego 8
Milan 7
Plano 7
Federal 4
Frankfurt am Main 4
Norwalk 4
Andover 3
Beijing 3
Boston 3
Fremont 3
San Mateo 3
Sofia 3
Amsterdam 2
Des Moines 2
Desio 2
Falls Church 2
La Spezia 2
Monteriggioni 2
Nanjing 2
Pomezia 2
Santa Clara 2
Seville 2
Treviso 2
Zanjan 2
Bucharest 1
Caselle Torinese 1
Cotonou 1
Dhaka 1
Florence 1
Gunzenhausen 1
Hefei 1
Hyderabad 1
Jinan 1
Kilburn 1
Kunming 1
Liverpool 1
London 1
Matelica 1
Nanning 1
New Bedfont 1
Phoenix 1
Pune 1
Redwood City 1
Reggio Calabria 1
Stockholm 1
São Paulo 1
Thessaloniki 1
Toronto 1
Varese 1
Totale 645
Nome #
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 121
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 103
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes 95
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal medicine wards. a multicenter study 85
Interplay between Nox2 activity and platelet activation in patients with sepsis and septic shock. a prospective study 80
null 77
Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19. a multicenter observational study 69
null 49
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21 47
null 45
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 41
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome 40
Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards. A propensity score-adjusted analysis 39
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 30
Fatal fungemia by biofilm-producing Trichosporon asahii in a liver transplant candidate 15
Compassionate use of meropenem/vaborbactam for infections caused by kpc-producing Klebsiella pneumoniae. A multicentre study 14
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia 11
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 10
Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections. A Retrospective observational multicenter study 10
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 7
Totale 988
Categoria #
all - tutte 3.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 0 0 2 12 15 30 23 19 19 17 6 13
2020/2021101 5 8 1 0 1 4 18 6 9 35 11 3
2021/2022168 5 4 8 9 12 11 8 18 18 6 42 27
2022/2023201 32 41 9 18 29 11 6 13 15 3 15 9
2023/2024149 12 13 10 30 5 16 11 14 7 8 10 13
2024/202537 6 11 20 0 0 0 0 0 0 0 0 0
Totale 988